p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor function
Zijun Y. Xu‐Monette(Duke University), Ken H. Young(Duke Medical Center), Michael Møller(Hospital South West Jutland), Karen Dybkær(Aalborg University Hospital), Govind Bhagat(Columbia University Irving Medical Center), Benjamin M. Parsons(Gundersen Health System), Maurilio Ponzoni(San Raffaele University of Rome), Eric D. Hsi(Mayo Clinic), J. Han van Krieken(Radboud University Nijmegen), Attilio Orazi(Texas Tech University), Alexandar Tzankov(University of Basel), Carlo Visco(University of Verona), Kristy L. Richards(University of North Carolina at Chapel Hill), April Chiu(Mayo Clinic), Youli Zu(Methodist Hospital), Miguel Á. Piris(Hospital Universitario Fundación Jiménez Díaz), Santiago Montes‐Moreno(Universidad de Cantabria), Shanxiang Zhang(Indiana University School of Medicine), Ganiraju C. Manyam(The University of Texas MD Anderson Cancer Center), Andrés J.M. Ferreri(Vita-Salute San Raffaele University), Jooryung Huh(Asan Medical Center), Xin Li(China Medical University), Li Zhang(Chongqing Emergency Medical Center), Xiaoying Zhao(Handan College), Yi Xia(The University of Texas MD Anderson Cancer Center), William W.L. Choi(Chinese University of Hong Kong), L. Jeffrey Medeiros(Delaware Division of Libraries), Xiao-Xiao Wang(The University of Texas MD Anderson Cancer Center), Jane N. Winter(Northwestern University)
Cited by 25
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k